Understanding the mechanisms of ER activity in breast cancer has been a majorresearch interest and recent genomic advances have revealed extraordinary insightsinto how ER mediates gene transcription and what occurs during endocrine resistance.This review discusses our current understanding on ER activity, with an emphasis onseveral evolving, but important areas of ER biology. This evidence concerns the gene ESR1 and breast carcinoma.